BOULDER, Colo.--(BUSINESS WIRE)-- Covidien (NYSE: COV), a leading global provider of healthcare products and recognized innovator in mechanical ventilation and respiratory care devices, today ...

BOULDER, Colo.--(BUSINESS WIRE)--Covidien (NYSE: COV), a leading global provider of healthcare products and recognized innovator in patient monitoring and respiratory care devices, today announced the ...

Covidien (NYSE: COV), a leading global supplier of healthcare products, today announced the integration of its Nellcor™ OxiMax™ oximetry system into Philips IntelliVue and M-Series patient monitors.

This regulatory milestone follows news from earlier this year, when the company announced positive verification study results for its Nellcor pulse oximetry system with Nell-EQ intelligent processor.

New device is the only commercially available bedside monitor designed for home care and sleep study settings DUBLIN, Ireland--(BUSINESS WIRE)-- Covidien (NYSE: COV) today announced CE Mark approval ...

A literature search was done for this briefing in accordance with the interim process and methods statement. This briefing includes the most relevant or best available published evidence relating to ...

This regulatory milestone follows news from earlier this year, when the company announced positive verification study results for its Nellcor™ pulse oximetry system with Nell-EQ™ intelligent processor ...

The Nasal Alar SpO 2 sensor (Xhale Assurance) is a disposable, single patient use pulse oximetry sensor that clips onto the nasal ala, the fleshy part of the side of the nose. The sensor is indicated ...